UM Regents Vote on Pharma Manufacturing
The University of Michigan board of regents authorized 11 items that required disclosure under the state’s conflict-of-interest statute, in votes taken at the board’s July 19, 2012 meeting. The law requires that regents vote on potential conflict-of-interest disclosures related to university staff, faculty or students.
Among them was an item related to consulting in support of a pharmaceutical manufacturing facility at the North Campus Research Complex (NCRC). That project is the Michigan Advanced Development and Manufacturing Center – an entity created by UM to seek a U.S. Dept. of Defense contract to develop pharmaceutical manufacturing at the former Pfizer site. At this point, the conflict-of-interest item is a retroactive disclosure of consulting services with NanoBio Corp. from Feb. 10, 2012, through June 30, 2012, with a … [Full Story]